Eugene Y. Chan, M.D. is a physician-innovator who has made numerous contributions to genomic technologies, medical devices, and instrumentation. He is the Founder, President, and Chief Scientific Officer of the DNA Medicine Institute, an organization focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Eugene graduated from Harvard University summa cum laude and the Harvard Medical School, MIT HST program with honors. He completed his internship in internal medicine at Harvard Medical School's Brigham and Women's Hospital and is licensed to practice medicine in multiple states. While taking a six year hiatus from his medical training, he was the Founder, Chairman, and CEO of U.S. Genomics, a company that has completed two commercial DNA analysis instruments based on his principle of single molecule fluorescent DNA scanning. The technology is also being utilized for diagnosing complex infectious diseases without the need for blood cultures. U.S. Genomics has raised over $115 million in funding and includes the involvement of multiple Nobel Laureates and National Academy of Sciences members. He holds more than 39 U.S., world, issued, and pending patents. He has been recognized as one of Esquire magazine's "Best and Brightest" and MIT Technology Review's "Top 100 Innovators Under 35." His work has been praised in the pages of Fortune, Forbes, Newsweek, Scientific American, and The New York Times.